Multi-label classification using deep belief networks for virtual screening of multi-target drug

Nowadays, the trend of drugs leads to multi-target drug. A drug compound may have one or more protein targets. Drugs that have multi-target protein considered to be more potential in the future. Virtual screening (VS) is a computational technique used in drug discovery to find the protein target of drugs. Virtual screening is usually based on compound similarity or database docking. Thus, the identification for multi-target drug compounds based on structure classification still remain as a challenging task The identification problem of multi-target protein from drug compounds can be categorized into multi-label classification problem. The purpose of this research is to find a new approach for multi-target drug virtual screening using machine learning technique. In this paper, the classification has been done by using combination of Deep Belief Networks (DBN) and Binary Relevance data transformation method. This research used two subset of protein target classes from DUD-E docking website. Feature were obtained from molecular fingerprint descriptor. The experiments result show that DBN can be used as virtual screening method for multi-target drug and outperform the DUD-E benchmarking.

[1]  Michael M. Mysinger,et al.  Directory of Useful Decoys, Enhanced (DUD-E): Better Ligands and Decoys for Better Benchmarking , 2012, Journal of medicinal chemistry.

[2]  Grigorios Tsoumakas,et al.  Mining Multi-label Data , 2010, Data Mining and Knowledge Discovery Handbook.

[3]  Jian-Yu Shi,et al.  Predicting drug-target interaction for new drugs using enhanced similarity measures and super-target clustering. , 2015, Methods.

[4]  John P. Overington,et al.  How many drug targets are there? , 2006, Nature Reviews Drug Discovery.

[5]  Frederick P. Roth,et al.  Chemical substructures that enrich for biological activity , 2008, Bioinform..

[6]  Jin-jian Lu,et al.  Multi-Target Drugs: The Trend of Drug Research and Development , 2012, PloS one.

[7]  Fernando Pérez-Cruz,et al.  Deep Learning for Multi-label Classification , 2014, ArXiv.

[8]  Yee Whye Teh,et al.  A Fast Learning Algorithm for Deep Belief Nets , 2006, Neural Computation.

[9]  Deepak Singla,et al.  DrugMint: a webserver for predicting and designing of drug-like molecules , 2013, Biology Direct.

[10]  Manjunath Ghate,et al.  Ligand and structure-based approaches for the identification of SIRT1 activators. , 2015, Chemico-biological interactions.

[11]  Geoffrey E. Hinton,et al.  Reducing the Dimensionality of Data with Neural Networks , 2006, Science.

[12]  Chuang Liu,et al.  Prediction of Drug-Target Interactions and Drug Repositioning via Network-Based Inference , 2012, PLoS Comput. Biol..

[13]  Yanli Wang,et al.  PubChem: Integrated Platform of Small Molecules and Biological Activities , 2008 .

[14]  Geoffrey E. Hinton Learning multiple layers of representation , 2007, Trends in Cognitive Sciences.

[15]  Ito Wasito,et al.  Deep belief networks for ligand-based virtual screening of drug design , 2016 .

[16]  Ying Liu,et al.  Machine Learning for Drug Design , 2015 .